Orally ingested PAHs also cause toxicity and even affect the pharmacokinetic behavior of some therapeutic agents. Toward this end, bioaccessibility is being used as a tool to assess the risk of PAHs via dietary exposures. Areas covered This review covers some in vitro bioaccessibility models for PAHs that have been used for the past one-and-a-half decade. 